Moderna stock surged to a five-year high Friday on the back of its Street-walloping vaccine sales and guidance hike for the year. The post Moderna Hits Five-Year High On Sales Beat; But The Real Story Is Still Its Cancer Vaccine appeared first on Investor's Business Daily.
CryptoAlerta — análise de criptomoedas e mercado em tempo real